Product logins

Find logins to all Clarivate products below.


Urological Devices | Market Insights | Asia Pacific (Supplemental) | 2021

Despite the impact of the ongoing COVID-19 pandemic, the Asia Pacific urological device market will continue to expand through 2029 due to growing patient awareness of urological treatments in this region. In particular, rising use of minimally invasive laser treatments for urinary stones and BPH will drive sales in several segments of this market, thus fueling overall market growth. However, the market will be negatively affected in the short term by the global COVID-19 pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…